Pharmaceutical Process Scale-Up, 3rd Edition: Drug Development and Industrial Pharmacy
Pharmaceutical Process Scale-Up, 3rd Edition: Drug Development and Industrial Pharmacy
Pharmaceutical Process Scale-Up, 3rd Edition: Drug Development and Industrial Pharmacy
Linda A. Felton
To cite this article: Linda A. Felton (2012) Pharmaceutical Process Scale-Up, 3rd edition, Drug
Development and Industrial Pharmacy, 38:4, 512-512, DOI: 10.3109/03639045.2011.633523
Book Reviews
Pharmaceutical Process Scale-Up, 3rd edition perspective. Much of this chapter is focused on model-
Michael Levin, Editor based process optimization. Risk assessment and
Informa Healthcare, New York City, 2011 understanding risks during scale-up are discussed in
Chapter 3. This new chapter provides insight into assess-
The development of pharmaceutical products generally ing and controlling risk, focusing predominately on API
begins in a research laboratory where quantities of the manufacturing. Other notable new chapters cover pro-
active pharmaceutical ingredient (API) are limited and cess validation, scale up of continuous blending, and
quantities of product needed are small. For commer- virtual scale up of manufacturing processes. The updated
cial products, however, large quantities of materials are Appendices include internet links for FDA, EU, and ICH
required and significant problems may be encountered harmonization guidelines.
during this scale up phase of the drug development pro- As with the previous edition, much of the book is
cess. The text, Pharmaceutical Process Scale-Up, covers devoted to specific processes, such as powder blend-
both theoretical and practical aspects of ‘scaling up’ API ing and granulation, roller compaction, extrusion and
and drug product batch size. This is the third edition of spheronization, tableting, capsule filling, and coating.
the text, demonstrating the interest in the subject from Semi-solids, liquids, and parenterals are also covered.
the pharmaceutical industry. As with the previous edi- Overall, the book provides practical approaches for scal-
tion, the editor has compiled well known engineers and ing up of both drugs and drug products. This book will be
formulation scientists to author the chapters. valuable to formulation scientists, process engineers, and
The text begins with a chapter on dimensional analysis anyone else involved in scale up activities. The references
and scale up in theory as well as industrial application. to PAT, quality by design, and question-based review will
Simple examples are provided to demonstrate the theo- particularly appeal to validation and quality assurance
retical fundamentals of dimensional analysis, although personnel.
mathematically these examples become increasingly
complex. The next chapter focuses on process scale-up, Linda A. Felton, Ph.D.
validation, and optimization using process analytical University of New Mexico
technologies (PAT) and is written from an engineering College of Pharmacy
512